Kyle Potts

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

Victoria Hall, Sarah Foulkes, Ayoub Saei et al. · The Lancet · 2021 · 829 citations · Full text

Vaccination, Preventive Medicine, Vaccine Development +11

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Victoria Hall, Sarah Foulkes, André Charlett et al. · The Lancet · 2021 · 732 citations · Full text

Long Covid, Sars-cov-2 Infection Rates, Covid-19 Pandemic +6

Deletion of <i>F4L</i> (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models

Kyle Potts, Chad R. Irwin, Nicole A. Favis et al. · EMBO Molecular Medicine · 2017 · 48 citations · Full text

A B1a–natural IgG–neutrophil axis is impaired in viral- and steroid-associated aspergillosis

Nicole Sarden, Sarthak Sinha, Kyle Potts et al. · Science Translational Medicine · 2022 · 43 citations

Oncolytic Viruses in the Treatment of Bladder Cancer

Kyle Potts, Mary Hitt, Ronald B. Moore · Advances in Urology · 2012 · 24 citations · Full text

Bladder Carcinoma, Urology, Novel Therapy +13